Articles

Structure Optimization and Structure-Activity Relationship Study of a Kind of Type II FAK Inhibitors with N-Phenylpyrazole Ureas

  • Gong Chaochao ,
  • Tan Hanyi ,
  • Zhang Qian
Expand
  • Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203

Received date: 2018-05-08

  Revised date: 2018-06-07

  Online published: 2018-06-29

Supported by

Project supported by the Shanghai Science and Technology Commission Support Project for Biological Medicine (No. 14431900600) and the School of Pharmacy of Fudan University Fusion Fund (No. RO-MY201708).

Abstract

The structure modification and optimization focused on the N-phenylpyrazole motif of the lead compound 2 were conducted on basis of the structural features of focal adhesion kinase (FAK) allosteric hydrophobic pockets. Nine aimed compounds were designed and synthesized, among which four compounds maintained the inhibitory activity against FAK at the same level as 2. Especially, N-(4-(5-(3-(4-(6-amino-9H-purin-9-yl) phenyl) ureido)-3-(tert-butyl)-1H-pyrazol-1-yl) phenyl) ace-tamide (9e) demonstrated 2-fold higher inhibition potency than that of the lead compound with the IC50 value of 41 nmol/L. It is suggested that the bioactivity could be further improved by introducing more proper groups at the 4-position of phenyl to increase the interactions between the substituents and the residues around them.

Cite this article

Gong Chaochao , Tan Hanyi , Zhang Qian . Structure Optimization and Structure-Activity Relationship Study of a Kind of Type II FAK Inhibitors with N-Phenylpyrazole Ureas[J]. Chinese Journal of Organic Chemistry, 2018 , 38(11) : 3086 -3093 . DOI: 10.6023/cjoc201805020

References

[1] Zhao, X.; Guan, J. Adv. Drug Delivery Rev. 2011, 63, 610.
[2] Heinrich, T.; Seenisamy, J.; Emmanuvel, L.; Kulkarni, S. S.; Bomke, J.; Rohdich, F.; Greiner, H.; Esdar, C.; Krier, M.; Gradler, U.; Musilet, D. J. Med. Chem. 2013, 56, 1160.
[3] Parsons, J. T. J. Cell Sci. 2003, 116, 1409.
[4] Sulzmaier, F. J.; Jean, C.; Schlaepfer, D. D. Nat. Rev. Cancer 2014, 14, 598.
[5] Schneider, G.; Geppert, T.; Hartenfeller, M.; Reisen, F.; Klenner, A.; Reutlinger, M.; Hähnke, V.; Hiss, J. A.; Zettl, H.; Keppner, S.; Spänkuch, B.; Schneideret, P. Future Med. Chem. 2011, 3, 415.
[6] Peng, W.; Zhang, X. W.; Zhang, C.; Wang, F.; You, Q. D. Chin. J. New Drug 2012, 21, 890(in Chinese). (彭文, 张小猛, 张仓, 王芳, 尤启冬, 中国新药杂志, 2012, 21, 890.)
[7] Dietrich, J.; Hulme, C.; Hurley, L. H. Bioorg. Med. Chem. 2010, 18, 5738.
[8] Infante, J. R.; Camidge, D. R.; Mileshkin, L. R.; Chen, E. X.; Hicks, R. J.; Rischin, D.; Fingert, H.; Pierce, K. J.; Xu, H. P.; Roberts, W. G.; Shreeve, S. M.; Burris, H. A.; Siu, L. L. J. Clin. Oncol. 2012, 30, 1527.
[9] Zhang, J.; He, D. H.; Zajac-Kaye, M.; Hochwald, S. N. Cell Cycle 2014, 13, 3143.
[10] Ott, G. R.; Cheng, M.; Learn, K. S.; Wagner, J.; Gingrich, D. E.; Lisko, J. G.; Curry, M.; Mesaros, E. F.; Ghose, A. K.; Quail, M. R.; Wan, W. H.; Lu, L. H.; Dobrzanski, P.; Albom, M. S.; Angeles, T. S.; Wells-Knecht, K.; Huang, Z. Q.; Aimone, L. D.; Bruckheimer, E.; Anderson, N.; Friedman, J.; Fernandez, S. V.; Ator, M. A.; Ruggeri, B. A.; Dorsey, B. D. J. Med. Chem. 2016, 59, 7478.
[11] Tanjoni, I.; Colin Walsh, C.; Uryu, S.; Tomar, A.; Nam, J.; Mielgo, A.; Lim, S.; Liang, C. X.; Koenig, M.; Patel, N.; Kwok, C.; McMahon, G.; Stupack, D. G.; Schlaepfer, D. D. Cancer Biol. Ther. 2010, 9, 764.
[12] Kang, Y.; Hu, W.; Ivan, C.; Dalton, H. J.; Miyake, T.; Pecot, C. V.; Zand, B.; Liu, T.; Huang, J.; Jennings, N. B.; Rupaimoole, R.; Taylor, M.; Pradeep, S.; Wu, S. Y.; Lu, C. H.; Wen, Y. F.; Huang, J. F.; Liu, J. S.; Sood A. K. J. Natl. Cancer Inst. 2013, 105, 1485.
[13] Iwatani, M.; Iwata, H.; Okabe, A.; Skene, R. J.; Tomita, N.; Hayashi, Y.; Aramaki, Y.; Hosfield, D. J.; Hori, A.; Baba, A.; Miki, H. Eur. J. Med. Chem. 2013, 61, 49.
[14] Johnson, L. N.; Noble, M.; Owen, D. J. Cell 1996, 85, 149.
[15] Grädler, U.; Bomke, J.; Musil, D.; Dresing, V.; Lehmann, M.; Hölzemann, G.; Greiner, H.; Esdar, C.; Krier, M.; Heinrich, T. Bioorg. Med. Chem. Lett. 2013, 23, 5401.
[16] Váňa, L.; Vrzal, L.; DvoRáková, H.; Himl, M.; Linhart, I. Synth. Commun. 2014, 44, 788.
[17] Simay, A.; Takacs, K.; Horvath, K.; Dvortsak, P. Acta Chim. Acad. Sci. Hung. 1980, 105, 127.

Outlines

/